You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(02696.HK):松江基地(二)一期項目第三階段投資不超8.18億元
格隆匯 11-09 17:45

格隆匯11月9日丨復宏漢霖(02696.HK)發佈公吿,董事會已於近日議決批准對位於上海松江區目前在建的復宏漢霖生物醫藥產業化基地(二)(“松江基地(二)”)一期項目第三階段投資不超過人民幣8.18億元,用於固定資產投資。

根據披露,截至該公吿日,松江基地(二)一期項目已完成樁基工程,兩幢主要生產樓已完成結構封頂、主體結構驗收和所有建築部分施工,生產輔助樓的結構封頂以及主體結構驗收工作完成,原液線及製劑線等主要生產設備全面啟動工廠驗收測試。

松江基地(二)預計總規劃面積為200畝,建設完成後,松江基地(二)將成為集團單克隆抗體生物藥研發、中試及生產基地,這將進一步增強集團在核心業務領域的市場競爭力,並滿足集團生物類似藥、生物創新藥產品的全球商業化生產需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account